Use 17282 for a malignant lesion in the same anatomic group measuring 1.1–2.0 cm. This code applies when the lesion measures 2.1–3.0 cm.
On this page
CMS RVU26D · Effective 2026-10-01
17283 Lesion destruction Medicare reimbursement rates in Pennsylvania
Destruction of a malignant skin lesion measuring 2.1–3.0 cm on the face, ears, eyelids, nose, lips, or mucous membranes. Compare 17283 office and facility rates across CMS payment localities in Pennsylvania.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 17283 in Pennsylvania?
Pennsylvania has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
$225.41–$246.47
2 of 2 localities have a supported rate.
Facility setting
$136.80–$145.99
2 of 2 localities have a supported rate.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Dermatology procedure
About 17283: Malignant lesion destruction, face or similar site
Destruction of a malignant skin lesion measuring 2.1–3.0 cm on the face, ears, eyelids, nose, lips, or mucous membranes.
This service destroys a malignant skin lesion on the face, ears, eyelids, nose, lips, or mucous membranes, with the lesion measuring 2.1–3.0 cm. A dermatologist or other qualified clinician may use an appropriate destructive method, such as cryosurgery, electrosurgery, or laser treatment, in an office or facility setting. The code is for malignant lesions, not benign growths or precancerous lesions treated with destruction.
Select the code using both the anatomic group and the documented lesion size; codes for other body sites have separate size series. The record should support the malignant diagnosis, treated site, lesion measurement, and destructive service performed. Medicare assigns a 10-day global period, so related postoperative visits during that period are included. When multiple procedures are performed in the same session, the highest-valued procedure is paid in full and other procedures are subject to the standard multiple-procedure reduction. Modifier 50 is inappropriate for this code. Medicare does not pay an assistant at surgery, and co-surgeons and team surgery are not permitted.
CMS billing rules for 17283
- Global period
- Minor procedure with a 10-day global period: related postoperative visits for 10 days are included.
- Multiple procedures
- Standard multiple procedure reduction: the highest-valued procedure is paid in full and others at 50% when performed in the same session.
- Bilateral procedures
- Bilateral adjustment does not apply; the descriptor or anatomy makes modifier 50 inappropriate.
- Assistant at surgery
- Statutory restriction: assistant at surgery is not paid.
- Co-surgeons
- Co-surgeons not permitted.
- Team surgery
- Team surgery not permitted.
Where the value comes from
- Work RVU2.62 · 37%
- Practice expense (office) RVU4.24 · 60%
- Malpractice RVU0.25 · 4%
10.1K
Medicare services in 2024 · #1459 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
17283 compared with similar codes
Office rates for Pennsylvania, from the same CMS release.
Use 17284 for a lesion in the same anatomic group measuring 3.1–4.0 cm; this code ends at 3.0 cm.
This code is selected for the face, ears, eyelids, nose, lips, or mucous membranes. Code 17263 is for a 2.1–3.0 cm malignant lesion on the trunk, arms, or legs.
This code covers the face and related sites. Code 17273 covers the scalp, neck, hands, feet, or genitalia for a lesion in the corresponding size range.
Compare 17283 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Metropolitan Philadelphia →
Office / nonfacility
$246.47
Facility
$145.99
Rest Of Pennsylvania →
Office / nonfacility
$225.41
Facility
$136.80
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
17283 billing questions
How is this code distinguished from 17282?
Both cover malignant lesions in the same anatomic group. Use 17283 for a lesion measuring 2.1–3.0 cm; 17282 covers the smaller 1.1–2.0 cm range.
When should a code from the 17260 series be used instead?
The 17260 series is for malignant lesions on the trunk, arms, or legs. This code is for lesions on the face, ears, eyelids, nose, lips, or mucous membranes.
Are related postoperative visits billed separately?
Related postoperative visits during the 10-day global period are included in the procedure.
Can modifier 50 be used for lesions on both sides?
No. The CMS bilateral adjustment does not apply to this code, and modifier 50 is inappropriate.
How are other procedures performed in the same session paid?
The highest-valued procedure is paid in full, and other procedures are subject to the standard multiple-procedure reduction.
Can an assistant or co-surgeon be reported?
Medicare does not pay an assistant at surgery for this code. Co-surgeons and team surgery are not permitted.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
